Ensysce Biosciences earnings were -$11.8M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ENSC earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$3.6M, up 28.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ENSC reported annual earnings of -$10.2M, with 27.4% growth. The next ENSC earnings date is Aug 12, 2026.
Ensysce Biosciences Earnings Reports & History FAQ
What were Ensysce Biosciences's earnings last quarter?
Ensysce Biosciences (NASDAQ: ENSC) reported Q1 2026 earnings per share (EPS) of -$0.52, up 62.59% year over year. Total ENSC earnings for the quarter were -$3.56 million. In the same quarter last year, Ensysce Biosciences's earnings per share (EPS) was -$1.39.
The next ENSC earnings date is Aug 12, 2026. Add ENSC to your watchlist to be reminded of Ensysce Biosciences's next earnings date.
Is Ensysce Biosciences profitable or losing money?
As of the last Ensysce Biosciences earnings report, Ensysce Biosciences is currently losing money. Ensysce Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$11.79 million, a 72.92% increase year over year.
What was ENSC's earnings growth in the past year?
As of Ensysce Biosciences's earnings date in Q3 2026, Ensysce Biosciences's earnings has grown year over year. ENSC earnings in the past year totalled -$11.79 million.
What are Ensysce Biosciences's earnings expectations?
The current EPS estimate for Ensysce Biosciences's earnings report in Aug 12, 2026 is -$0.50.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.